Results of a Phase 3 study of IVO vs IO for Previously Untreated Older Patients with CLL and Impact of COVID-19 (Alliance)
         Google Scholar   
Citation:
J Clin Oncol vol 41 (suppl 16) 7500
Meeting Instance:
ASCO 2023
Year:
2023
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10 CA180882, U24CA196171; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                   
Networks:
LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-OH007, MCRC, OH027, OH070   
Study
Alliance-A041702
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: